Perioperative and long-term outcomes after percutaneous thrombectomy of arteriovenous dialysis access grafts

• Published in: Journal of vascular surgery 2020-12, Vol.72 (6), p.2107-2112
• Main Authors: Arinze, Nkiruka, MD, Ryan, Tyler, BS, Pillai, Rohit, Vilvendhan, Rajendran, MD, Farber, Alik, MD, Jones, Douglas W., MD, Rybin, Denis, PhD, Levin, Scott R., MD, Cheng, Thomas W., MS, Siracuse, Jeffrey J., MD
• Format: Article
• Language: English
• Subjects: Aged; Arteriovenous graft; Arteriovenous Shunt, Surgical - adverse effects; Dialysis access; Embolectomy; Endovascular; Female; Graft Occlusion, Vascular - diagnostic imaging; Graft Occlusion, Vascular - etiology; Graft Occlusion, Vascular - physiopathology; Graft Occlusion, Vascular - surgery; Humans; Male; Middle Aged; Renal Dialysis - adverse effects; Retrospective Studies; Risk Assessment; Risk Factors; Surgery; Thrombectomy; Thrombectomy - adverse effects; Thrombolytic Therapy; Time Factors; Treatment Outcome; Vascular Patency; Vascular surgery
• ISSN: 0741-5214; 1097-6809
• DOI: 10.1016/j.jvs.2020.03.032

AbstractObjectiveMaintenance of functional arteriovenous grafts (AVGs) for dialysis is difficult secondary to low primary patency, need for reinterventions, and limited alternative dialysis access options. We assessed our experience with percutaneous thrombectomy for treatment of occluded AVGs. MethodsWe performed a retrospective analysis of all percutaneous thrombectomies for AVGs from 2015 to 2017. These were generally performed using mechanical thrombectomy and occasional chemical tissue plasminogen activator thrombolysis, over-the-wire balloon embolectomy for inflow, and adjunctive inflow and outflow interventions as necessary. Perioperative outcomes, long-term patency, reinterventions, and need for new permanent access placement were analyzed. ResultsThere were 218 percutaneous thrombectomies performed on 86 AVGs in 77 patients. Approximately half (53.2%) of the patients were male and 68.8% were black. Mean age was 61.1 ± 13.0 years. At the time of thrombectomy, 73.8% underwent venous outflow interventions and 4.5% underwent arterial inflow interventions. Within 30 days, 24.8% of declotted grafts underwent repeated percutaneous thrombectomy, 14.3% required tunneled dialysis catheter placement, 4% developed minor access site or graft infections, and one patient underwent surgical arterial thrombectomy for arm ischemia. There were no venous thromboembolic, cardiopulmonary, or cerebrovascular complications or clinically significant pulmonary embolism. At 1 year and 3 years after percutaneous thrombectomy, freedom from repeated thrombosis was 37% and 18%, respectively, and freedom from new dialysis access placement was 66% and 51%, respectively. Overall patient survival was 82% at 3 years. ConclusionsPercutaneous thrombectomy of AVGs is safe and is associated with acceptable patency rates. This minimally invasive method extends AVG use for these high-risk patients with limited dialysis access options.